NCT00030043View on ClinicalTrials.gov

An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2001

Study Completion Date

August 31, 2003

Conditions
Neurofibromatosis 2
Interventions
DEVICE

Penetrating auditory brainstem implant

Trial Locations (3)

90057

House Ear Institute, Los Angeles

Unknown

Huntington Medical Research Institutes, Pasadena

Cochlear Corporation, Englewood

All Listed Sponsors
lead

FDA Office of Orphan Products Development

FED

NCT00030043 - An Implant for Hearing Loss Due to Removal of Neurofibromatosis 2 Tumors | Biotech Hunter | Biotech Hunter